Adrenal myelolipoma is a rare, benign tumor of the adrenal gland that is composed of mature fat and bone marrow cells. It is most commonly found in adults and is usually asymptomatic. However, in some cases, it can cause complications due to its size and location. In this article, we will explore the impact of adrenal myelolipoma on the human body and discuss the diagnosis, treatment, and management of this condition.
Adrenal myelolipoma (AML) is a rare benign tumor of the adrenal gland composed of mature fat and bone marrow cells. It is most commonly found in adults, usually asymptomatic, and is usually discovered incidentally during imaging. The tumor is usually small, less than 5cm in diameter, and is located in the adrenal cortex. It is important to note that AML is not cancerous and does not spread outside of the adrenal gland.
The exact cause of adrenal myelolipoma is not known, but there are some risk factors that may increase the likelihood of developing this condition. These include:
Adrenal myelolipoma is usually asymptomatic and is usually discovered incidentally during imaging. However, in some cases, it can cause complications due to its size and location. The most common symptoms of AML include:
The diagnosis of adrenal myelolipoma is usually made through imaging studies, such as CT or MRI scans. These scans can help to identify the size and location of the tumor. In some cases, a biopsy may be performed to confirm the diagnosis.
Adrenal myelolipoma is usually asymptomatic and does not require treatment. However, if the tumor is large or is causing complications, surgery may be recommended to remove it. In some cases, medications may be prescribed to manage symptoms or to reduce the size of the tumor.
Adrenal myelolipoma is a rare, benign tumor of the adrenal gland that is composed of mature fat and bone marrow cells. It is most commonly found in adults and is usually asymptomatic. However, in some cases, it can cause complications due to its size and location. Diagnosis is usually made through imaging studies, and treatment may include surgery or medication to manage symptoms. It is important to recognize the potential impact of adrenal myelolipoma on the human body and to be aware of the diagnosis, treatment, and management of this condition.
1.
Alkem introduces cetuximab under the trade name Cetuxa in India.
2.
A US health panel advises starting mammograms at age 40 rather than 50.
3.
DBT Reduced Suicide Attempts in Adolescents with Bipolar Disorder.
4.
Fitness levels for the heart and lungs are linked to a lower mortality from cancer in men.
5.
Reduced Suicide Rates in Cancer Patients; Enhanced Circadian Rhythm; HIV Vaccine for Cancer Patients?
1.
Oncology Trials Roadmap: From Drug Discovery to Delivery and Patient Access
2.
Understanding the Causes and Symptoms of Cavernous Sinus Thrombosis
3.
ERASur: Evaluating Total Ablative Therapy in Limited Metastatic Colorectal Cancer
4.
The Next Generation of Precision: How Multi-Specific Antibodies are Redefining Oncology's Future - A 2025 Review
5.
Bridging Disciplines: Medical Oncology vs Surgical Oncology in the Era of Multidisciplinary Cancer Care
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
2.
From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD
3.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV
5.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation